Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Cardiovascular Disorders
Published in: BMC Cardiovascular Disorders 1/2018

Open Access 01-12-2018 | Debate

Simplification and optimization of transcatheter aortic valve implantation – fast-track course without compromising safety and efficacy

Authors: Manik Chopra, Ngai H. V. Luk, Ole De Backer, Lars Søndergaard

Published in: BMC Cardiovascular Disorders | Issue 1/2018

Login to get access

Abstract

Transcatheter aortic valve implantation (TAVI) has become an established therapeutic option for patients with symptomatic, severe aortic valve stenosis. Ageing of the Western and Asian population and expansion of indications for TAVI will lead to a substantial increase in the number of TAVI procedures performed worldwide within the next decades. In line with the maturation of TAVI over the past few years, there has also been a significant simplification and optimisation of the TAVI procedure. A minimalist TAVI procedure and fast-track TAVI course have been shown to have distinct advantages over the more traditional TAVI approach. The aim of this manuscript is to discuss strategies of TAVI simplification and optimization, with special focus on fast-track TAVI, without compromising safety and efficacy.
Literature
1.
Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006–8.CrossRefPubMed
2.
Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.CrossRefPubMed
3.
Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.CrossRefPubMed
4.
Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016;374(17):1609–20.CrossRefPubMed
5.
Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, et al. Surgical or Transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321–31.CrossRefPubMed
6.
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–91.CrossRefPubMed
7.
Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–619.CrossRefPubMed
8.
Goel SS, Ige M, Tuzcu EM, Ellis SG, Stewart WJ, Svensson LG, et al. Severe aortic stenosis and coronary artery disease: implications for management in the transcatheter aortic valve replacement era: a comprehensive review. J Am Coll Cardiol. 2013;62(1):1–10.CrossRefPubMed
9.
Coylewright M, Mack MJ, Holmes DR Jr, O'Gara PT. A call for an evidence-based approach to the heart team for patients with severe aortic stenosis. J Am Coll Cardiol. 2015;65(14):1472–80.CrossRefPubMed
10.
Babaliaros V, Devireddy C, Lerakis S, Leonardi R, Iturra SA, Mavromatis K, et al. Comparison of Transfemoral transcatheter aortic valve replacement performed in the catheterisation laboratory (minimalistic approach) versus hybrid operating room (Standard approach): outcomes and cost analysis. JACC Cardiovasc Interv. 2014 Aug;7(8):898–904.CrossRefPubMed
11.
Frangieh AH, Ott I, Michel J, Shivaraju A, Joner M, Mayr NP, et al. Standardized minimalistic Transfemoral Transcatheter aortic valve replacement (TAVR) using the SAPIEN 3 device: stepwise description, feasibility, and safety from a large consecutive single-center single-operator cohort. Structural Heart. 2017;1(3–4):169–78.CrossRef
12.
Gurevich S, Oestreich B, Kelly RF, Mbai M, Bertog S, Ringsred K, et al. Outcomes of transcatheter aortic valve replacement using a minimalist approach. Cardiovasc Revasc Med. 2018;19(2):192–5.CrossRefPubMed
13.
Barbanti M, Tamburino C. Optimisation of TAVI: is it mature enough to be defined as a PCI-like procedure? EuroIntervention. 2015;11 Suppl W:W110–3.CrossRefPubMed
14.
Jensen HA, Condado JF, Devireddy C, Binongo J, Leshnower BG, Babaliaros V, et al. Minimalist transcatheter aortic valve replacement: the new standard for surgeons and cardiologists using transfemoral access? J Thorac Cardiovasc Surg. 2015;150(4):833–9.CrossRefPubMed
15.
Ribera A, Slof J, Andrea R, Falces C, Gutiérrez E, Del Valle-Fernández R, et al. Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: cost-utility and its determinants. Int J Cardiol. 2015;182:321–8.CrossRefPubMed
16.
Barbanti M, Binder RK, Freeman M, Wood DA, Leipsic J, Cheung A, et al. Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement. EuroIntervention. 2013;9(8):929–35.CrossRefPubMed
17.
Zhao A, Minhui H, Li X, Zhiyun X. A meta-analysis of transfemoral versus transapical transcatheter aortic valve implantation on 30-day and 1-year outcomes. Heart Surg Forum. 2015;18(4):E161–6.CrossRefPubMed
18.
Siontis GC, Praz F, Pilgrim T, Mavridis D, Verma S, Salanti G, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J. 2016;37(47):3503–12.CrossRefPubMed
19.
Israel M, Barbash IM, Barbanti M, Webb J, Molina-Martin De Nicolas J, Abramowitz Y, et al. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation. Eur Heart J. 2015;36(47):3370–9.CrossRef
20.
Stortecky S, Wenaweser P, Diehm N, Pilgrim T, Huber C, Rosskopf AB, et al. Percutaneous management of vascular complications in patients undergoing transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2012 May;5(5):515–24.CrossRefPubMed
21.
Marcantuono R, Gutsche J, Burke-Julien M, Anwaruddin S, Augoustides JG, Jones D, et al. Rationale, development, implementation, and initial results of a fast track protocol for transfemoral transcatheter aortic valve replacement (TAVR). Catheter Cardiovasc Interv. 2015;85(4):648–54.CrossRefPubMed
22.
Dvir D, Jhaveri R, Pichard AD. The minimalist approach for transcatheter aortic valve replacement in high-risk patients. JACC Cardiovasc Interv. 2012;5(5):468–9.CrossRefPubMed
23.
Jabbar A, Khaurana A, Mohammed A, Das R, Zaman A, Edwards R. Local versus general Anaesthesia in Transcatheter aortic valve replacement. Am J Cardiol. 2016;118(11):1712–6.CrossRefPubMed
24.
Villablanca PA, Mohananey D, Nikolic K, Bangalore S, Slovut DP, Mathew V, et al. Comparision of local versus general anaesthesia in patients undergoing transcatheter aortic valve replacement: A meta-analysis. Catheter Cardiovasc Interv. 2018;91(2):330–42.CrossRefPubMed
25.
Fröhlich GM, Lansky AJ, Webb J, Roffi M, Toggweiler S, Reinthaler M, et al. Local versus general anaesthesia for transcatheter aortic valve implantation (TAVR) – Systematic review and meta-analysis. BMC Med. 2014;12:41.CrossRefPubMedPubMedCentral
26.
Krishnaswamy A, Latib A, Malik A, Bertoldi L, Poddar KL, Chieffo A, et al. Resource utilization for transfemoral transcatheter aortic valve replacement: an international comparision. Catheter Cardiovasc Interv. 2016;87(1):145–51.CrossRefPubMed
27.
Cilingiroglu M, Marmagkiolis K. A glimpse into future of TAVR. Catheter Cardiovasc Interv. 2016;87(1):152–3.CrossRefPubMed
28.
Hayek SS, Corrigan FE 3rd, Condado JF, Lin S, Howell S, MacNamara JP, et al. Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Comparing Transthoracic versus Transesophageal Echocardiographic Guidance. J Am Soc Echocardiogr. 2017;30(6):533–40.CrossRefPubMed
29.
Lauck SB, Kwon JY, Wood DA, Baumbusch J, Norekvål TM, Htun N, et al. Avoidance of urinary catheterization to minimize in-hospital complications after transcatheter aortic valve implantation: an observational study. Eur J Cardiovasc Nurs. 2018;17(1):66–74.CrossRefPubMed
30.
31.
Faurie B, Abdellaoui M, Wautot F, Staat P, Champagnac D, Wintzer-Wehekind J, et al. Rapid pacing using the left ventricular guidewire: Reviving an old technique to simplify BAV and TAVI procedures. Catheter Cardiovasc Interv. 2016;88(6):988–93.CrossRefPubMed
32.
Jørgensen TH, De Backer O, Gerds TA, Bieliauskas G, Svendsen JH, Søndergaard L. Immediate post-procedural 12-Lead electrocardiography as predictor of late conduction defects after Transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11(15):1509–18.CrossRefPubMed
33.
Toggweiler S, Stortecky S, Holy E, Zuk K, Cuculi F, Nietlispach F, et al. The electrocardiogram after Transcatheter aortic valve replacement determines the risk for post-procedural high-degree AV block and the need for telemetry monitoring. JACC Cardiovasc Interv. 2016;9(12):1269–76.CrossRefPubMed
34.
Wood DA. Could a Simplified Transcatheter Aortic Valve Replacement Procedure Eliminate Post –Operative Delirium? JACC Cardiovasc Interv. 2016;9(2):169–70.CrossRefPubMed
35.
Abawi M, Nijhoff F, Agostoni P, Emmelot-Vonk MH, de Vries R, Doevendans PA, et al. Incidence, predictive factors, and effect of delirium after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2016;9(2):160–8.CrossRefPubMed
36.
Lauck SB, Wood DA, Baumbusch J, Kwon JY, Stub D, Achtem L, et al. Vancouver transcatheter aortic valve replacement clinical pathway: minimalist approach, standardized care, and discharge criteria to reduce length of stay. Circ Cardiovasc Qual Outcomes. 2016;9(3):312–21.CrossRefPubMed
37.
Sud M, Qui F, Austin PC, Ko DT, Wood D, Czarnecki A, et al. Short Length of Stay After Elective Transfemoral Transcatheter Aortic Valve Replacement is Not Associated With Increased Early or Late Readmission Risk. J Am Heart Assoc. 2017;6(4):e005460.
38.
Durand E, Eltchaninoff H, Canville A, Bouhzam N, Godin M, Tron C, et al. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis. Am J Cardiol. 2015;115(8):1116–22.CrossRefPubMed
39.
Barbanti M, Capranzano P, Ohno Y, Attizzani GF, Gulino S, Imme S, et al. Early discharge after transfemoral transcatheter aortic valve implantation. Heart. 2015;101(18):1485–90.CrossRefPubMed
40.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017 AHA/ACC focused update of the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;70(2):252–89.CrossRefPubMed
41.
Ahmad Y, Demir O, Rajkumar C, Howard JP, Shun-Shin M, Cook C, et al. Optimal antiplatelet strategy after transcatheter aortic valve implantation: a meta-analysis. Open Heart. 2018;5(1):e000748.CrossRefPubMedPubMedCentral
42.
Søndergaard L, Sigitas C, Chopra M, Bieliauskas G, De Backer O. Leaflet Thrombosis after TAVI. Eur Heart J. 2017;38(36):2702–3.CrossRefPubMed
43.
Zanettini R, Gatto G, Mori I, Pozzoni MB, Pelenghi S, Martinelli L, et al. Cardiac rehabilitation and mid-term follow-up after transcatheter aortic valve implantation. J Geriatr Cardiol. 2014;11(4):279–85.PubMedPubMedCentral
44.
Capodanno D, Petronio AS, Prendergast B, Eltchaninoff H, Vahanian A, Modine T, et al. Standardized definations of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprostheic valves: a consensus statement from the European Association of Percutaneus Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2017;38(45):3382–90.CrossRefPubMed
Metadata
Title
Simplification and optimization of transcatheter aortic valve implantation – fast-track course without compromising safety and efficacy
Authors
Manik Chopra
Ngai H. V. Luk
Ole De Backer
Lars Søndergaard
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2018
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-018-0976-0

Other articles of this Issue 1/2018

BMC Cardiovascular Disorders 1/2018 Go to the issue

Research article

Profile of patients with hypertensive urgency and emergency presenting to an urban emergency department of a tertiary referral hospital in Tanzania

Research article

Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database

Research article

The evaluation of the aortic annulus displacement during cardiac cycle using magnetic resonance imaging

Case report

Lipomatous hypertrophy of the atrial septum – a benign heart anomaly causing unexpected surgical problems: a case report

Research article

Impact of clinical presentation and presence of coronary sclerosis on long-term outcome of patients with non-obstructive coronary artery disease

Research article

A meta-analysis of the efficacy of allopurinol in reducing the incidence of myocardial infarction following coronary artery bypass grafting

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits